"Navigating the Modern News Zoo so you don't have to."
Friday, October 24, 2025
Nerandomilast slows decline in forced vital capacity in idiopathic pulmonary fibrosis
For U.S. patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slows the decline in forced vital capacity (FVC), according to a study presented at CHEST 2025, the annual meeting of the American College of Chest Physicians, held from Oct. 19 to 22 in Chicago.
👉 Full Story
Google Pixel 9a Is Only $349!!!
- Fetterman Tells Democrats To ‘Cut The Shit’ After His Colleagues Tanked Bill To Pay Troops - Adam Pack And Caden Olson
- An In-depth Look at Boeing 737 Max's Recent Issues: Safety Concerns and Industry Implications - Bertha Stephens
- What To Expect With Stomach Cancer Treatment - Carrie Madormo, RN, MPH
- How James Gunn Turned A Legendary Sci-Fi Actor Into DC's New, Hidden Secret Weapon - Jonathan Klotz
- Extremely Lusty, Graphic, Heartfelt Sci-Fi Series Is Here To Top Peacemaker In Every Way - Jonathan Klotz
- Police chase runaway inflatable pumpkin through Ohio town
Worse Than Hillary AND Kamala? - Oh No 😟
- Unveiling the Mystery: The OpenAI Chaos - Sean George
- Tron: Ares Stumbles Out of the Gate — Opens Below Morbius - Staff
- Claude can now compartmentalize as part of a major memory upgrade - Igor Bonifacic
- Research finds that 77% of data engineers have heavier workloads despite AI tools: Here's why and what to do about it
- Oldest living person in America celebrates birthday, secret to long life
- Back To The Future And Lord Of The Rings Stars Combine In A Legendary TV Show - Chris Snellgrove
